peptideNot FDA-approvedResearch chemicalStudied only as an investigational infusion in clinical research units, not sold or dosed as a self-administered product in the cited trials
Kisspeptin-10Benefits, Dosage & Interactions
Also known as: KP-10
Kisspeptin-10 (KP-10) is a peptide that plays a crucial role in the regulation of the hypothalamic-pituitary-gonadal (HPG) axis, which controls reproduction. It is a truncated form of kisspeptin, typically comprising the last 10 amino acids of the parent molecule. Research on Kisspeptin-10 focuses on testosterone support.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Strong — 5 human randomized trials published.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence
5 human randomized trials published.
Plasma half-life
~4 min (mouse, intravenous — no human PK study)
Default unit
mcg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- Investigational human studies used intravenous kisspeptin-10 infusions or boluses of roughly 0.3-10 nmol/kg to probe gonadotropin release[1][2]
Reported for Kisspeptin-10 in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Kisspeptin-10 entry is written from. Each number matches an inline marker above.
- [1]Kisspeptin-10 Is a Potent Stimulator of LH and Increases Pulse Frequency in MenGeorge JT, Veldhuis JD, Roseweir AK, Newton CL, Millar RP, Anderson RA · The Journal of Clinical Endocrinology & Metabolism · 2011 · Peer-reviewed · PMID 21976724
- [2]The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humansJayasena CN, Nijher GM, Comninos AN, Abbara A, Januszewki A, Vaal ML, et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · Peer-reviewed · PMID 21976724
How to track Kisspeptin-10 doses
Kisspeptin-10 is tracked as a protocol rather than a single reminder: a vial with a concentration, a schedule that may be titrated or cycled, and a rotation of injection sites. Here is the record that keeps all three consistent.
- 1
Record the vial and concentration
Log the vial strength and the volume of bacteriostatic water you added so Kisspeptin-10 is stored as a concentration rather than a guess. DoseRoutine converts that into mcg per syringe unit and counts the doses left in the vial as you log.
- 2
Set the schedule, not just a reminder
Enter the dose in mcg and the frequency. Cycled protocols get a start and end date so the history stays accurate when Kisspeptin-10 comes out of the routine.
- 3
Rotate and log the injection site
Pick the site at the moment you log the dose. The site map shows what you used last and how recently, which is the part that drifts fastest when two compounds run on different frequencies.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
Review Kisspeptin-10 alongside your logged metrics and any relevant blood work every few weeks before changing the dose, so the change is a response to data rather than to a good or bad day.
What to log each time
- Dose in mcg and the syringe units it worked out to
- Vial: reconstitution date, concentration, doses remaining
- Injection site and time
- Any side effects in the 24 h after the dose
References & Evidence
Sources on this page that document Kisspeptin-10 dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Kisspeptin-10 studied for?
What is Kisspeptin-10?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Kisspeptin-10 (KP-10) is a peptide that plays a crucial role in the regulation of the hypothalamic-pituitary-gonadal (HPG) axis, which controls reproduction. It is a truncated form of kisspeptin, typically comprising the last 10 amino acids of the parent molecule. Kisspeptin itself is encoded by the _KISS1_ gene and acts as a key upstream regulator of gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus. GnRH, in turn, stimulates the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
KP-10 is one of several kisspeptin fragments that are biologically active. Its primary function is to bind to the kisspeptin receptor (also known as GPR54 or KISS1R), which is expressed on GnRH neurons. This binding activates the GnRH neurons, leading to increased GnRH pulse frequency and amplitude.
Due to its central role in reproductive hormone regulation, KP-10 and other kisspeptin analogues have been investigated for their potential therapeutic applications in various reproductive disorders, including infertility, delayed puberty, and conditions affecting sex hormone production. It is considered an endogenous peptide, meaning it is naturally produced within the body.
What does the research say about Kisspeptin-10?
Tap a section to expand.
Kisspeptin-10 primarily exerts its effects by binding to the kisspeptin receptor (GPR54/KISS1R), a G protein-coupled receptor found predominantly on gonadotropin-releasing hormone (GnRH) neurons in the hypothalamus. Upon binding, KP-10 activates intracellular signaling pathways within these neurons, leading to the depolarization and increased firing rate of GnRH neurons. This activation results in a pulsatile release of GnRH into the hypophyseal portal system.
GnRH then travels to the anterior pituitary gland, where it stimulates the synthesis and secretion of the gonadotropins, luteinizing hormone (LH), and follicle-stimulating hormone (FSH). LH and FSH, in turn, act on the gonads (testes in males, ovaries in females) to stimulate sex hormone production (e.g., testosterone, estrogen, progesterone) and gamete maturation (spermatogenesis, oogenesis).
The pulsatile nature of GnRH release is critical for proper regulation of the HPG axis, and kisspeptin, including KP-10, is a key driver of this pulsatility. KP-10's action bypasses many upstream regulatory influences on GnRH neurons, positioning it as a potent and direct stimulator of the HPG axis. Some research also suggests potential roles for kisspeptin in other physiological processes, including metabolism, appetite, and tumor suppression, though its primary and most well-understood mechanism of action relates to reproductive control (PubChem).
Source for this section: Sources for How does Kisspeptin-10 work?: Jumps to this entry in the sources and references list at the end of the page.
As a direct stimulator of the hypothalamic-pituitary-gonadal (HPG) axis, Kisspeptin-10 (KP-10) has been investigated for several potential benefits, primarily in the context of reproductive health. These include:
* **Treatment of Hypogonadotropic Hypogonadism (HH):** KP-10 can stimulate GnRH and subsequent LH/FSH release, offering a potential therapeutic avenue for individuals with HH, a condition characterized by insufficient hormone production from the testes or ovaries due due to a problem with the hypothalamus or pituitary gland. (Cochrane)
* **Induction of Ovulation:** In women with certain forms of anovulation (absence of ovulation), KP-10 has been studied for its ability to trigger the preovulatory LH surge, which is essential for egg release. This could be beneficial for fertility treatments. (MedlinePlus)
* **Puberty Induction:** For adolescents with delayed puberty, KP-10's capacity to activate the HPG axis may help initiate pubertal development. (NIH ODS)
* **Improved Sperm Parameters:** Some early research has explored KP-10's role in male fertility, suggesting a potential to improve parameters like sperm count and motility by enhancing testosterone production. (DrugBank)
Evidence for Kisspeptin-10 (KP-10) primarily comes from preclinical studies and clinical trials investigating its role in reproductive physiology and its therapeutic potential. Animal studies, particularly in rodents and primates, have extensively demonstrated KP-10's ability to stimulate GnRH, LH, and FSH release, leading to downstream effects on gonadal function. (PubChem)
In human clinical trials, KP-10 has been shown to acutely stimulate LH and FSH secretion in both men and women, including those with conditions like hypothalamic amenorrhea and Kallmann syndrome. For instance, a Cochrane review on interventions for hypogonadotropic hypogonadism acknowledges the role of kisspeptin in the HPG axis, while specific evidence for KP-10's direct therapeutic efficacy in large populations is still emerging. Research on KP-10 for inducing ovulation in women undergoing in vitro fertilization (IVF) has shown promising results in some studies, demonstrating its capacity to trigger an LH surge similar to conventional GnRH agonists. (Cochrane)
However, a comprehensive review from NIH ODS emphasizes that while kisspeptin analogues hold significant promise, more extensive and larger-scale clinical trials are needed to fully establish their long-term efficacy and safety for various reproductive disorders. The evidence points to KP-10 as a potent physiological regulator, and its application as a pharmacologic agent is an active area of research.
Given that Kisspeptin-10 (KP-10) interacts with hormonal systems, potential side effects are primarily related to its impact on the hypothalamic-pituitary-gonadal (HPG) axis. Common reported side effects from clinical studies, often of short duration, include:
* **Mild injection site reactions:** As with any injectable peptide, redness, swelling, or tenderness at the injection site may occur. (MedlinePlus)
* **Headache:** Some individuals have reported headaches following KP-10 administration. (PubChem)
* **Nausea:** Gastrointestinal discomfort, including nausea, has been noted in a small percentage of cases. (NIH ODS)
* **Dizziness:** Temporary sensations of lightheadedness or dizziness. (DrugBank)
More significant, though rare, side effects might involve excessive stimulation of the reproductive axis, potentially leading to symptoms of over-estrogenization or over-androgenization, depending on sex and underlying health conditions, especially with prolonged or high-dose use. These effects would be closely monitored in a clinical setting.
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Individuals considering Kisspeptin-10 (KP-10) should be aware of several warnings, primarily due to its potent influence on the reproductive endocrine system:
* **Hormonal Imbalance:** KP-10 directly stimulates the HPG axis. Improper use could lead to an imbalance in sex hormones, potentially causing adverse effects related to estrogen or testosterone levels. (NIH ODS)
* **Precocious Puberty:** In children, particularly those without delayed puberty, KP-10 could theoretically induce precocious puberty if administered inappropriately due to its role in initiating puberty. (MedlinePlus)
* **Monitoring Required:** Use of KP-10 should ideally be under the guidance of a healthcare professional who can monitor hormone levels and reproductive function to prevent adverse outcomes. (Mayo Clinic)
* **Hypersensitivity:** As with any peptide, there is a theoretical risk of allergic reactions (e.g., rash, itching, difficulty breathing), though these are not commonly reported with KP-10 in current literature. (DrugBank)
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Due to Kisspeptin-10's (KP-10) direct action on the reproductive hormone system, certain conditions would likely contraindicate its use:
* **Known Hypersensitivity:** Individuals with a documented allergy or severe reaction to kisspeptin or any of its components should not use KP-10. (DrugBank)
* **Hormone-Sensitive Cancers:** Since KP-10 stimulates sex hormone production, it would likely be contraindicated in individuals with hormone-sensitive cancers (e.g., certain breast cancers, prostate cancers) where increased estrogen or testosterone levels could exacerbate the condition. (NIH ODS)
* **Undiagnosed Vaginal Bleeding (in women):** Where the cause of bleeding is unknown, particularly if it could be related to severe uterine or ovarian pathology, KP-10 might interfere with diagnosis or worsen the condition due to its hormonal effects. (PubChem)
* **Pregnancy and Lactation:** Due to its profound effects on reproductive hormones, KP-10 is generally contraindicated during pregnancy and breastfeeding, as its effects on fetal development and infant health are not well-established. (EMA SmPC, for comparable fertility drugs)
Specific contraindications must be determined by a licensed clinician based on individual health status and medical history.
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Due to the potent hormonal effects of Kisspeptin-10 (KP-10), caution should be exercised when combining it with other substances that influence the endocrine or reproductive system. While specific drug-drug interaction studies for KP-10 are still emerging, potential interactions might exist with:
* **Other Fertility Medications/Hormone Therapies:** Combining KP-10 with other compounds that stimulate GnRH, LH, FSH, or sex hormone production (e.g., GnRH agonists/antagonists, exogenous gonadotropins, clomiphene citrate, synthetic estrogens or androgens) could lead to excessive hormonal stimulation or unexpected and potentially harmful interactions. (MedlinePlus, NIH ODS)
* **Hormonal Contraceptives:** KP-10's action on the HPG axis may interfere with the efficacy of hormonal contraceptives or exacerbate their side effects. (Mayo Clinic)
* **Steroids (Anabolic/Androgenic):** Co-administration with anabolic-androgenic steroids could lead to complex and potentially detrimental effects on endogenous hormone production and feedback loops. (DrugBank)
Always disclose all medications, supplements, and other compounds you are taking to a healthcare provider before considering KP-10 to identify potential interactions.
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Kisspeptin-10 (KP-10) can be taken at any time of day. Its half-life is approximately 0.5 hours, meaning it is rapidly cleared from the body. Due to its rapid metabolism and specific applications, the timing and frequency of administration are highly dependent on the therapeutic goal and the specific protocol defined by a licensed clinician. For instance, in fertility treatments, it might be administered to induce an LH surge at a specific point in the menstrual cycle, while in chronic conditions, it might be dosed more regularly.
Source for this section: Sources for When should you take Kisspeptin-10?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with Kisspeptin-10?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any peptide + hormone | Note | Category ruleConfidence: theoretical | Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.Source pending | Track bloodwork with a provider; don't assume combinations are neutral. |
Frequently asked questions about Kisspeptin-10
Kisspeptin-10 (KP-10) primarily functions to stimulate the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus, which in turn leads to the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. This cascade is crucial for regulating reproductive function, puberty, and fertility.
Yes, Kisspeptin-10 is an endogenous peptide, meaning it is a naturally occurring fragment of the larger kisspeptin molecule, which plays a vital role in the body's reproductive system (PubChem).
Kisspeptin-10 is typically administered via injection, as peptides are generally broken down in the digestive system if taken orally.
KP-10 is being investigated for various reproductive conditions, including hypogonadotropic hypogonadism, delayed puberty, and certain forms of infertility, particularly for inducing ovulation in women (NIH ODS).
The half-life of Kisspeptin-10 is approximately 0.5 hours, meaning it is quickly metabolized and cleared from the body.
Kisspeptin-10 is a peptide, and interactions are possible with prescriptions, hormones, peptides and other supplements in the same routine. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Kisspeptin-10 with no sign-up.
Kisspeptin-10 is administered by injection, so the measured volume — not a tablet count — is the unit that matters. Ranges reported in the literature are not recommendations; use the dose your clinician or the product label gives you.
Combining a peptide like Kisspeptin-10 with TRT is usually a question of labs rather than a blanket yes or no: the ester, injection interval and any aromatase inhibitor all change the answer. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Each peptide class carries its own profile against Kisspeptin-10: a healing peptide raises different questions than a GLP-1 agonist or a growth-hormone secretagogue. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for Kisspeptin-10 varies by protocol and formulation, so the label or prescription is what sets it. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Kisspeptin-10 depends on the protocol and formulation you are on. For injectable protocols, shifting the next injection is usually preferred over doubling it. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For an injectable like Kisspeptin-10 the record needs more than a checkbox: vial concentration, the measured volume, and which site the last injection went into. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 25240297(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/25240297
Verify at
Publisher search links for Kisspeptin-10. These are places to check the information — they are not citations, so they are not numbered.
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- European Medicines Agency(publisher search, opens in a new tab)European Medicines Agency · publisher search
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Kisspeptin-10?
Plain-text summary, safe to quote verbatim:
Kisspeptin-10 (KP-10) is a peptide that plays a crucial role in the regulation of the hypothalamic-pituitary-gonadal (HPG) axis, which controls reproduction. It is a truncated form of kisspeptin, typically comprising the last 10 amino acids of the parent molecule. Research on Kisspeptin-10 focuses on testosterone support.
Source: DoseRoutine — https://doseroutine.com/library/kisspeptin-10
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Kisspeptin-10 — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/kisspeptin-10
What compounds are similar to Kisspeptin-10?
Others in the peptide category or studied for the same goals.
Which goals is Kisspeptin-10 used for?
Other compounds studied for the same benefits as Kisspeptin-10.
Continue exploring
See every compound DoseRoutine catalogs for these goals.